Document is current
Any future updates will be listed below
-
Authors
Levin, Nikita https://orcid.org/0000-0001-6969-7350
Saylan, Cemil Can https://orcid.org/0000-0002-3534-8352
Lapin, Joel
Demyanenko, Yana https://orcid.org/0000-0002-6628-1912
Yang, Kevin L. https://orcid.org/0000-0002-8569-4579
Sidda, John
Nesvizhskii, Alexey I. https://orcid.org/0000-0002-2806-7819
Wilhelm, Mathias https://orcid.org/0000-0002-9224-3258
Mohammed, Shabaz https://orcid.org/0000-0003-2640-9560
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 24 February 2026
First Online: 23 March 2026
Competing interests
: A.I.N. is the Founder of Fragmatics and serves on the scientific advisory boards of Protai Bio, Infinitopes and Mobilion Systems. A.I.N. is also a paid consultant for Novartis. A.I.N. has a financial interest due to the licensing of MSFragger and IonQuant to commercial entities. M.W. is a founder and shareholder of MSAID GmbH with no operational role, and a member of the scientific advisory board of Momentum Biotechnologies. The other authors declare no competing interests.
